Japanese Researchers Study Substance For Multi-Strain Flu Fight
This article was originally published in PharmAsia News
Researchers at a Japan institute developed what they believe could protect against many strains of influenza virus by targeting infected cells. Researchers at the National Institute of Infectious Diseases, NOF say they developed a substance that works by concentrating on the infected cells instead of providing immunity. Immunity is lost when a cell mutates, and the researchers are studying whether their substance can fight the H5N1 virus despite its constant mutations. (Click here for more - a subscription may be required
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.